Initial Dip Leads to Records For The Dow & The S&P – $AAPL $FATE $INMB $INVO & Healthcare Move Higher!
- Published Aug 16, 2021
- Apple
- Current Coverage
- Fate Therapeutics, Inc.
- InMed Pharmaceuticals Inc.
- INmune Bio Inc.
- INVO Bioscience
- Market News
Happy First Day Of The Week!
I hope that all of you were successful in the markets today. As for the markets, we digested an early morning selloff for a good 1.5 hours prior to seeing at least the S&P 500 & the Dow turn green. Many blamed the downturn on the head spinning and unfortunate ‘hat trick’ of events that hit investors over the weekend. The stories included the widely reported explosive growth of the Delta variant/increased pressures on growth, the realization that the Taliban seized control of Afghanistan as the US pulls out, & the stories that the Fed may begin tapering its purchases as soon as Oct. 2021. The yield curve also saw volatility in reaction of these recent events, as the 10-yr treasury yield closed lower by 4 basis points at 1.26% & the 2-yr yield moved down 2 basis points to close at .20%. The U.S. Dollar Index closed up .1% at 92.62. Gold prices moved up $8 to close at $1,788 and silver closed at $23.87, +$.12.
At the end of the day, Monday’s markets proved to be yet another split between the ‘haves’ (large caps) and the ‘have nots’ (small/growth issues) when you looked at the indices. The S&P 500 closed at 4,479.71 (+.26%) another new record close, the Dow 30 closed at a record high too at 35,625.40 (+.31%). The healthcare sector was strong today moving up 1.1% as was Apple (AAPL), which realized another new record high to help all concerns closing at $151.12, +1.35, but Tesla (TSLA) dropped off to close at 686.17, -4.32% as stories regarding the autopilot probe blossomed. The Energy sector closed down sharply by 1.8% as oil prices moved lower by .7% to close at $67.34/bbl. In addition, the materials sector was off .5%, the consumer discretionary was off .4%, & the financials slipped .2% adding the increased downward pressure as growth concerns increased. The smalls on the Russell 2000 also closed lower at 2,203.41 (-.89%), while the MicroCaps also ticked lower again as the iShares Micro-Cap ETF (IWC) closed at $141.75, (-1.44%).
The macroeconomic schedule delivered somewhat sobering news that the Empire State Manufacturing report for August fell to 18.3. Tomorrow’s schedule will be a bit busier and will produce the Retail Sales report for July, the Industrial Production and Capacity Utilization report for July, the Business Inventories report for June, & the NAHB Housing Market Index report for August.
BIOTECH INDICES LOWER – $FATE $INMB UP!
The SPDR S&P Biotech ETF (XBI) closed at $121.79, -2.27%, the iShares Nasdaq Biotechnology ETF (IBB) closed at $167.40, -1.18% & the NYSE ARCA Biotech Index (^BTK) closed at 5,740.69, -1.14%.
A couple of biotech stocks in the VP Watchlist rose today as follows:
- INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease including Alzheimer’s disease, closed at $16.88, +1.81% after hitting $17.38 in intraday trading,
- Fate Therapeutics (FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, closed at $87.63/share, +1.06%. The 52-wk high is $121.16.
TECH
The tech sector dropped to a session low dropping 1.1% during session prior to recovering somewhat by the end of the day. Shares of chip maker NVIDIA (NVDA) closed at $199.50, -1.18%. Amazon.com (AMZN) closed at 3,298.99, +.15%. According to Reuters, Amazon (AMZN) founder Jeff Bezos’s Blue Origin is suing the U.S Government over NASA’s awarding a $2.9B lunar lander contract to Tesla (TSLA) founder Elon Musk’s SpaceX.
MEMES MOVES
AMC Entertainment (AMC) closed at $35.69, +6.63% after reaching an intraday high of $36.14 and a low of $332.71 & GameStop (GME) also closed at $163.93, +.87%. “Short sellers alone aren’t enough to contain the bulls”, stated Jim Cramer during his Mad Money Recap last week.
Virgin Galactic Holdings (SPCE) closed at $25..33 down another .16% or more than 26% in the last week. Again, could we possibly be getting somewhere close to support levels?
Infamous ‘meme brokerage’ firm Robinhood Markets, Inc., (HOOD) closed at lower again today at $47.19, -6.79%, but still higher then IPO shares which were sold recently at $38! Are we coming back to IPO levels sometime soon as this shiny new nickel becomes dull?
Seanergy Maritime Holdings Corp. (NASDAQ: SHIP, $1.12, -4.27%). SHIP, the only pure-play Capesize ship-owner publicly listed in the US, announced last week that its Board of Directors has authorized a share repurchase plan. Under the Plan, the Company may repurchase up to $17 million of its outstanding common shares, representing approximately 10% of the Company’s market capitalization as of August 10, 2021.
VP WATCHLIST HIGHLIGHTS
Our complete VP Watchlist is a list that we believe deserves consideration for short term and long term portfolio adds that include Apple, Tesla, Disney & 8 other names currently. The dedicated pages for each of these companies will enable you to stay informed and learn more about these companies daily. Please review few of the updates on a few of the VP Watchlist companies below:
- Shares of VP Watchlist stock, INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease including Alzheimer’s disease, closed at $16.88, +1.81% after hitting $17.38 in intraday trading.
-
- On Wednesday, Aug. 4th, INmune Bio, Inc. reported its financial results for the second quarter ended June 30, 2021 and provided a business update. Raymond J Tesi, M.D., CEO/CMO of INmuneBio (INMB) stated, “We continue our planning and setup for a Phase 2 clinical trial of our lead candidate, XPRO™ (Xpro1595™), in patients with mild Alzheimer’s disease, which we plan to initiate by year-end. We have already demonstrated that XPRO™ can reduce neuroinflammation and decreases biomarkers of neurodegeneration and improve synaptic function. If successful in Phase 2, we believe XPRO™ has the potential to be among the most significant advancements in the treatment of Alzheimer’s Disease (AD) and other neurodegenerative diseases in many years. At the Alzheimer’s Association International Conference last week, we introduced a new biomarker – Apparent Fiber Density (AFD), a measure of axonal integrity measured by MRI. XPRO™ increases AFD in patients receiving 1mg/kg/week. We believe the novel non-invasive white matter analytics of white matter free water and apparent fiber density will be very useful in the development of XPRO™ in AD, Treatment Resistant Depression (TRD) and the many other CNS indications we hope to attack in the future. Last month, we treated the first patient in the first Phase 1 clinical trial of our NK cell priming platform, INKmune, in high-risk myelodysplastic syndrome (MDS). We are calling INKmune a pseudokine because, in vitro, it converts the resting NK cells into memory-like NK cells that can kill cancer cells as well or better than NK cells treated cytokines such as IL-12, IL-15 and IL-18 alone or in combination.”
-
- On July 26th, INmune Bio announced the design of its upcoming Phase 2 clinical trial of XProTM in patients diagnosed with mild Alzheimer’s disease (AD) at AAIC. The announcement was accompanied by the release of additional biomarker data from the Phase 1b AD trial that shows improvement in white matter (myelinated axons) that degenerate in AD patients. READ MORE.
- Fate Therapeutics (FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, closed at $87.63/share, +1.06%. The 52-wk high is $121.16.
-
- On August 4th, Fate reported business highlights and financial results for the second quarter ended June 30, 2021. Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics stated, “We are very pleased with the early clinical safety and activity we have observed with our off-the-shelf, iPSC-derived NK cell programs in relapsed / refractory lymphoma and acute myeloid leukemia, where interim Phase 1 data indicate FT516 and FT538 are well tolerated and can deliver complete responses for patients. We look forward to sharing additional clinical data from our FT516 and FT596 programs in B-cell lymphoma at our upcoming investor event. Additionally, treatment of the first patient with FT819, the first-ever iPSC-derived T-cell therapy to undergo clinical investigation, is a landmark achievement and further demonstrates the Company’s leadership in off-the-shelf, iPSC-derived cell therapy and the versatility of its proprietary iPSC Product Platform.”
-
- On Aug. 2 Fate announced that the first patient has been treated with FT819, an off-the-shelf chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies. FT819 is the first-ever CAR T-cell therapy derived from a clonal master induced pluripotent stem cell (iPSC) line, a renewable cell source that enables mass production of high quality, allogeneic CAR T cells with greater product consistency, off-the-shelf availability, and broader patient accessibility. FT819 is engineered with several first-of-kind features designed to improve the safety and efficacy of CAR T-cell therapy.
- INVO Bioscience (NASDAQ: INVO) is a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System. Shares of INVO closed at $4.25, +.24%, but popped to $4.44 in the aftermarkets up +4.47%.
-
- After the close today August 16th, INVO announced their financial and operating results for the second quarter ended June 30, 2021 and provided a business update. Steve Shum , CEO of INVO stated. “Our team made excellent progress during the second quarter of 2021 toward our key objectives, headlined by last week’s official opening of our first INVO Center practice in Birmingham, AlabamaWe feel INVO is now well positioned for success based on the following core foundational elements developed over the past 2 years. We believe there is a substantial underserved patient population with infertility challenges and a real need to expand access to treatment. In our opinion, this is a multi-billion-dollar market expansion opportunity, and INVOcell is well positioned to address the unmet medical need.”
-
- On Aug.2, INVO announced the Company’s first Joint Venture INVO Center practice in the United States, based in Birmingham, Alabama, was officially opening on August 9, 2021. Dr. Hammond commented, “With the opening of the country’s first INVOcell medical practice, we are advancing a core mission towards improving access to advanced fertility services for the many patients who would otherwise never have the opportunity. To date, we have already received numerous advanced inquiries via word of mouth and have dozens of patients scheduled for initial patient consultations who are eager to proceed with treatment. As we officially open the center next week, we expect to accelerate our marketing programs with the help of the INVO marketing team to enhance overall patient awareness around Innovative Fertility Specialists, An INVO Center.”
-
- On July 14th, INVO announced the appointment of world renowned women’s health expert, Dr. Barbara Levy, M.D., FACOG, FACS as the Company’s Senior VP, Global Clinical Integration to accelerate affordable infertility treatment INVOcell’s Global OB/GYN Clinical Integration Strategy. Dr. Levy is considered one of the most influential clinical executives in the world, recently serving as Vice President, Health Policy at the American College of Obstetricians and Gynecologists (ACOG) and chair of the American Medical Association/Specialty Society Relative Value Scale Update Committee. She joins INVO Bioscience to help further develop and accelerate the Company’s global OB/GYN channel strategy. Steve Shum, CEO of INVO Bioscience, said, “We are excited to have Dr. Levy join the INVO team to support our mission to bring care to the vast underserved patient population around the world experiencing infertility challenges. She has a clear understanding of the role that OB/GYNs can play in helping to democratize fertility care on a global basis by providing accessibility to affordable and effective treatments, the key hallmarks of the INVOcell technology. We look forward to leveraging her experience, relationships, and influence to accelerate our OB/GYN clinical implementation strategy in the years to come.”
- Shares of VP Watchlist firm, Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, closed at $3.13, -2.8% on 4.3M shares of trading volume after reaching $3.21 in intraday trading.
-
- On Aug 13th, Atossa announced financial results for the fiscal quarter ended June 30, 2021, and provided an update on recent company developments. “We continue to experience encouraging progress in our MBD and COVID-19 programs, with new regulatory approvals being granted in Sweden for a Phase 2 trial in MBD and authorization in Australia to commence a Phase 2 study of AT-H201 for respiratory illness associated with COVID-19. In the meantime, we continue to enjoy a strong balance sheet, which we have significantly expanded over the last three quarters and will facilitate our development plans over the near term. As we actively explore the possibility for strategic expansion into other areas where we might see near-term milestones and results, we also urge all of our shareholders to exercise their right to vote at our special stockholder’s meeting on September 7, 2021. We urge a vote in favor of the proposal to increase authorized shares, which will provide the Company with the flexibility to issue shares as part of these potential acquisitions, collaborations and partnerships, a common strategy successful biotech companies seeking to grow shareholder value employ in order to create a more attractive opportunity for all. We look forward to continuing to update our stockholders on these opportunities as they develop,” stated Dr. Steven Quay, Atossa’s President and Chief Executive Officer.
- InMed Pharmaceuticals, Inc. (NASDAQ: INM) is leading clinical-stage pharmaceutical company developing cannabinoid-based drug candidates for high unmet medical needs and IntegraSyn, a proprietary and cost effective manufacturing approach for synthesized rare cannabinoids. Shares of InMed closed trading at $2.35, -2.89%, but moved up to $2.41, +2.55% in the aftermarkets. The 52-wk range is $2.20 – $8.94. On July 9th, Roth Capital Partners analyst Scott Henry, CFA issued an update report with a BUY Rating titled, “INM: Favorable Take on BayMedica LOI” that includes a $11.50 12-Month Price target.
-
- On Aug.9th, I published an informative story titled “A Recent Discussion With The CEO of InMed Pharmaceuticals (NASDAQ: INM) Regarding Development Of IntegraSyn™, A Proprietary Manufacturing Approach To Economically Produce Pharmaceutical-Grade Cannabinoids” PLEASE READ NOW.
-
- On July 2nd, InMed announced that it had closed the previously announced private placement and after deducting the placement agent fees and estimated offering expenses payable by the Company, the Company received net proceeds of approximately US$11 million. H.C. Wainwright & Co. acted as the exclusive placement agent for the private placement. Under the terms of the private placement, an aggregate of 4,036,327 common shares (or common share equivalents in lieu thereof) and warrants to purchase up to an aggregate of 4,036,327 common shares were purchased, at an effective purchase price of US$2.973 per common share (or common stock equivalent in lieu thereof) and associated warrant. The warrants have an exercise price of US$2.848 per share, are exercisable immediately and have a term of five years. InMed intends to use the net proceeds from the offering to continue pipeline development, advance business development activities and for general working capital purposes.
-
- On June 29th, INM announced that it has entered into a non-binding letter of intent (the “LOI”) to acquire BayMedica Inc. (“BayMedica”), a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids. BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable, and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is currently planning additional rare cannabinoid launches for the coming year. In addition to their manufacturing and commercial activities in the health and wellness arena, BayMedica is researching cannabinoid analogs as potential drug candidates for pharmaceutical purposes. Those BayMedica proprietary compounds are based upon the structures of naturally-occurring cannabinoids and are designed to either augment the potential therapeutic effect against specific diseases or enhance product safety, or both.
Economic Reports
- On Monday, the macroeconomic schedule delivered the Empire State Manufacturing report for August fell to 18.3.
Investing & Inspiration
- “Like wildebeest and zebra migration across the Serengeti, investment managers and consultants, too, have a habit of running together and, every now and then, changing direction.” – Sanjaya Baru
- “If people are anything but enthusiastic about the information or ideas that they’re sharing, they’re either not that invested in what they’re doing – or they’re not communicating that investment effectively.” – Ana Kasparian
- “Life consists not in holding good cards but in playing those you hold well.” – Josh Billings
- “Friend, there’s no greater investment in life than in being a people builder. Relationships are more important than our accomplishments.” – Joel Osteen
- “It’s only natural that the heavy users help contribute to the investment to keep the Web healthy. That is the most important concept of net neutrality.” – Lowell McAdam
- “The more sand that has escaped from the hourglass of our life, the clearer we should see through it.” – Jean Paul
-
“Eliminate emotion from your investment program.” -John C. Bogle
- “Modern medical advances have helped millions of people live longer, healthier lives. We owe these improvements to decades of investment in medical research.” – Ike Skelton
- “In every investment, before I get involved or invest, I always see what the mindset of the founder, the CEO, is.” – Zaza Pachulia
- “An investment said to have an 80% chance of success sounds far more attractive than one with a 20% chance of failure. The mind can’t easily recognize that they are the same.” – Daniel Kahneman
- “The return on investment in global health is tremendous, and the biggest bang for the buck comes from vaccines. Vaccines are among the most successful and cost-effective health investments in history.” – Seth Berkley
- “Few things in the world are more powerful than a positive push. A smile. A world of optimism and hope. A ‘you can do it’ when things are tough.” – Richard M. DeVos
- “To be yourself in a world that is constantly trying to make you something else is the greatest accomplishment.” – Ralph Waldo Emerson
- “We all have dreams. But in order to make dreams come into reality, it takes an awful lot of determination, dedication, self-discipline, and effort.” – Jesse Owens
- “The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.” – William Arthur Ward- American Writer, Born 1921
- “Once you replace negative thoughts with positive ones, you’ll start having positive results.” – Willie Nelson
- “The secret of your future is hidden in your daily routine.” – Mike Murdock
- “If somebody puts you down or criticizes you, just keep on believing in yourself and turn it into something positive.” – Leah LaBelle
- “Opportunity is missed by most people because it is dressed in overalls and looks like work”. -Thomas A. Edison
- “Education is not only a ladder of opportunity, but it is also an investment in our future.” – Ed Markey
-
“Human behavior flows from three main sources: desire, emotion, and knowledge.” – Plato
- “We are what our thoughts have made us; so take care about what you think. Words are secondary. Thoughts live; they travel far.” – Swami Vivekananda
- “Success is not final, failure is not fatal: it is the courage to continue that counts.” – Winston Churchill
-
“If you don’t know where you are going, any road will get you there.” – Lewis Carroll
-
“Don’t worry about being a star, worry about doing good work, and all that will come to you.” – Ice Cube
-
“It is not in the stars to hold our destiny but in ourselves.” – William Shakespeare
- “Prediction is very difficult, especially if it’s about the future.” – Niels Bohr (Danish Physicist)
-
“It is indeed true that the stock market can forecast the business cycle.” -Paul Samuelson
-
“The wisest rule in investment is: when others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” – Jonathan Sacks
- “What lies behind you and what lies in front of you, pales in comparison to what lies inside of you.” – Ralph Waldo Emerson
- “Each new generation born is in effect an invasion of civilization by little barbarians, who must be civilized before it is too late.” – Thomas Sowell
- “Life is 10% what happens to you and 90% how you react to it.” – Charles R. Swindoll
- “The truth is you don’t know what is going to happen tomorrow. Life is a crazy ride, and nothing is guaranteed.” – Eminem
-
“View health as an investment, not an expense.” – John Quelch
-
“Opportunity does not knock, it presents itself when you beat down the door.” – Kyle Chandler
- “If you don’t know where you are going, any road will get you there.” – Lewis Carroll
- “Once you replace negative thoughts with positive ones, you’ll start having positive results.” – Willie Nelson
- “That which does not kill us makes us stronger.” – Friedrich Nietzsche
- “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” – Marie Curie
- “A problem is a chance for you to do your best.”– Duke Ellington
- “The best way to predict the future is to create it.” -Peter Drucker
- “I’m involved in the stock market, which is fun and, sometimes, very painful.” – Regis Philbin
- “Who owns the future? This is the question at the heart of every stock market.” – John Landgraf
- “One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute.” – William Feather
- “While I’m sure some millennials are concerned with the ethical issues involved in mining for diamonds, the main reason they steer clear of the gems is because, well, they’re a dumb investment.” – Ana Kasparian
- “The wisest rule in investment is: when others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” – Jonathan Sack
- “We must shift our thinking away from short-term gain toward long-term investment and sustainability, and always have the next generations in mind with every decision we make.” – Deb Haaland
- “The only way to have a friend is to be one.” – Ralph Waldo Emerson
- “If you believe in yourself and have dedication and pride – and never quit, you’ll be a winner. The price of victory is high but so are the rewards.” – Bear Bryant
-
“Investing in women’s lives is an investment in sustainable development, in human rights, in future generations – and consequently in our own long-term national interests.” -Liya Kebede
- “Success is not final, failure is not fatal: it is the courage to continue that counts.”– Winston Churchill
-
“Our greatest glory is not in never falling, but in rising every time we fall.” – Confucius
- “Give me a lever long enough and a fulcrum on which to place it, and I shall move the world.” – Archimedes
- “Who controls the past controls the future. Who controls the present controls the past.” – George Orwell
- “If you get up in the morning and think the future is going to be better, it is a bright day. Otherwise, it’s not.” – Elon Musk
- “The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.” – William Arthur Ward
- “Start where you are. Use what you have. Do what you can.” – Arthur Ashe
- “Netflix, Amazon, iTunes – whatever platforms emerge – we are looking at as having the same potential that home video had for the movie business. Which means there are entirely new opportunities to monetize our capital investment in content and do so in ways that work for distributors, for consumers and for creators.” – Bob Iger
-
“When you have no one to answer to, vendetta as investment strategy is as legitimate as anything.” – Carl Icahn
- “No other investment yields as great a return as the investment in education. An educated workforce is the foundation of every community and the future of every economy.” – Brad Henry
- “In my view, the biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. Not only is the mere drop in stock prices not risk, but it is an opportunity. Where else do you look for cheap stocks?” – Li Lu
-
“Modern medical advances have helped millions of people live longer, healthier lives.
-
We owe these improvements to decades of investment in medical research.”– Ike Skelton
-
“Stock market goes up or down, and you can’t adjust your portfolio based on the whims of the market, so you have to have a strategy in a position and stay true to that strategy and not pay attention to noise that could surround any particular investment.” – John Paulson
- “Your mindset matters. It affects everything – from the business and investment decisions you make, to the way you raise your children, to your stress levels and overall well-being.” – Peter Diamandis
- “Inflation destroys savings, impedes planning, and discourages investment. That means less productivity and a lower standard of living.” – Kevin Brady
- “Bitcoin, in the short or even long term, may turn out be a good investment in the same way that anything that is rare can be considered valuable. Like baseball cards. Or a Picasso.” – Andrew Ross Sorkin
- “I think you have to learn that there’s a company behind every stock and there’s only one real reason why stocks go up. Companies go from doing poorly to doing well or small companies grow to large companies.” – Peter Lynch
- “Historically, there has been a bull market in the commodities every 20 or 30 years.” – Jim Rogers
- “The markets generally are unpredictable, so that one has to have different scenarios. The idea that you can actually predict what’s going to happen contradicts my way of looking at the market.” – George Soros
- “Stop trying to predict the direction of the stock market, the economy or the elections.” – Warren Buffett
- “An important key to investing is to remember that stocks are not lottery tickets.” – Peter Lynch
- “Learn everyday, but especially from the experiences of others. It’s cheaper!” – John Bogle
- “When purchasing depressed stock in troubled companies, seek out the ones with the superior financial positions and avoid the ones with loads of bank debt.” – Peter Lynch
- “No stock price is too low for bears or too high for bulls.” – John F. Heerdink, Jr.
-
“Investment is most successful when it is most businesslike.” – Ben Graham
-
“Value stocks are about as exciting as watching grass grow, but have you ever noticed just how much your grass grows in a week?” – Christopher Browne
- “Even the intelligent investor is likely to need considerable willpower to keep from following the crowd.” – Benjamin Graham
- “Individual who cannot master their emotions are ill-suited to profit from the investment process.” – Benjamin Graham
- “I made my first investment at age eleven. I was wasting my life until then.” – Warren Buffet
- “I don’t look to jump over seven-foot bars; I look around for one-foot bars that I can step over.” — Warren Buffett
- “There are only three measurements that tell you nearly everything you need to know about your organization’s overall performance: employee engagement, customer satisfaction, and cash flow. It goes without saying that no company, small or large, can win over the long run without energized employees who believe in the mission and understand how to achieve it.” – Jack Welch, former CEO of GE
- “Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble” ― W
- “If you buy things you do not need, soon you will have to sell things you need.” – Warren Buffet
- “How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.” — Robert G. Allen
- “It’s far better to buy a wonderful company at a fair price, than a fair company at a wonderful price.” – Warren Buffett
- “A market downturn doesn’t bother us. It is an opportunity to increase our ownership of great companies with great management at good prices.” — Warren Buffett
- “Every once in a while, the market does something so stupid it takes your breath away.” — Jim Cramer
- “The person who starts simply with the idea of getting rich won’t succeed; you must have a larger ambition.” — John D. Rockefeller
- “Know what you own, and know why you own it.” – Peter Lynch
- “Although it’s easy to forget sometimes, a share is not a lottery ticket… it’s part ownership of a business.” – Peter Lynch
- “Wise spending is part of wise investing. And it’s never too late to start.” – Rhonda Katz
-
“Invest for the long haul. Don’t get too greedy and don’t get too scared.” – Shelby M.C. Davis
- “Fear incites human action far more urgently than does the impressive weight of historical evidence.”
-Jeremy Siegel - “With a good perspective on history, we can have a better understanding of the past and present, and thus a clear vision of the future.” — Carlos Slim Helu
- “If we like a business, we’re going to buy as much of it as we can and keep it as long as we can. And when we change our mind, we don’t take half measures.” – Warren Buffett
-
“The most contrarian thing of all is not to oppose the crowd but to think for yourself.” — Peter Thiel
-
“Never depend on a single income, make an investment to create a second source.” Warren Buffet
- “Games are won by players who focus on the playing field –- not by those whose eyes are glued to the scoreboard.”
― Warren Buffett - “The key to making money in stocks is not to get scared out of them.” – Peter Lynch
- “Courage taught me no matter how bad a crisis gets … any sound investment will eventually pay off.” — Carlos Slim Helu
- “Investing puts money to work. The only reason to save money is to invest it.” – Grant Cardone
- “As time goes on, I get more and more convinced that the right method of investment is to put fairly large sums into enterprises which one thinks one knows something about and in the management of which one thoroughly believes.” — John Maynard Keynes
- “Given a 10% chance of a 100 times payoff, you should take that bet every time.” — Jeff Bezos
- “Money is always eager and ready to work for anyone who is ready to employ it.” ― Idowu Koyenikan
- “The secret to investing is to figure out the value of something – and then pay a lot less.” – Joel Greenblatt
- “We don’t have an analytical advantage, we just look in the right place.” – Seth Klarman
- “Men, it has been well said, think in herds. It will be seen that they go mad in herds, while they only recover their senses slowly, and one by one.” – Charles Mackay
- “It’s not whether you’re right or wrong that’s important, but how much money you make when you’re right and how much you lose when you’re wrong.” – George Soros
- “No Price is too low for a bear or too high for a bull.” — Anonymous
- “Investment is an asset or item that is purchased with the hope that it will generate income or appreciate in the future.” Anonymous
- “Behind every stock is a company. Find out what it’s doing.” — Peter Lynch
- “Wise spending is part of wise investing. And it’s never too late to start.” –Rhonda Katz
- “It amazes me how people are often more willing to act based on little or no data than to use data that is a challenge to assemble.” ― Robert Shiller
- “A bull market is like sex. It feels best just before it ends.” — Barton Biggs
- “The investor’s chief problem — even his worst enemy — is likely to be himself.” — Benjamin Graham
- “No profession requires more hard work, intelligence, patience, and mental discipline than successful speculation.” – Robert Rhea
- “Money is like a sixth sense – and you can’t make use of the other five without it.” – William Somerset Maugham
- “Compound interest is the eighth wonder of the world. He who understands it, earns it. He who doesn’t, pays it.” — Albert Einstein
- “Never count on making a good sale. Have the purchase price be so attractive that even a mediocre sale gives good results” — Warren Buffett
- “The stock market is a device for transferring money from the impatient to the patient.” – Warren Buffett
- “Thousands of experts study overbought indicators, head-and-shoulder patterns, put-call ratios, the Fed’s policy on money supply…and they can’t predict markets with any useful consistency, any more than the gizzard squeezers could tell the Roman emperors when the Huns would attack.” – Peter Lynch
- “Investing puts money to work. The only reason to save money is to invest it.” – Grant Cardone
- “You cannot save time for your future use however you can invest time for your future.” – John F. Heerdink, Jr.
- “Know what you own, and know why you own it.” – Peter Lynch
- “Liquidity is only there when you don’t need it.” -Old Proverb
- “If you want to be a millionaire, start with a billion dollars and launch a new airline.” – Richard Branson
- “Fear incites human action far more urgently than does the impressive weight of historical evidence.” – Jeremy Siegel
- “In investing, what is comfortable is rarely profitable.” – Robert Arnott
- “Spend each day trying to be a little wiser than you were when you woke up.” – Charlie Munger
- “The entrance strategy is actually more important than the exit strategy.” – Edward Lampert
- “The rivers don’t drink their own water; Trees don’t eat their own fruits. The sun does not shine for itself, And flowers do not spread their fragrance For themselves. Living for others is a rule of nature” – Pope Francis
- “It is impossible to produce superior performance unless you do something different from the majority.” – John Templeton
- “An investment in knowledge pays the best interest.” – Benjamin Franklin.
- “I believe the returns on investment in the poor are just as exciting as successes achieved in the business arena, and they are even more meaningful!” -Bill Gates
- “Every portfolio benefits from bonds; they provide a cushion when the stock market hits a rough patch. But avoiding stocks completely could mean your investment won’t grow any faster than the rate of inflation.” – Suze Orman
- “The tax on capital gains directly affects investment decisions, the mobility, and flow of risk capital… the ease or difficulty experienced by new ventures in obtaining capital, and thereby the strength and potential for growth in the economy.” – John F. Kennedy
- “If all the economists were laid end to end, they’d never reach a conclusion. -George Bernard Shaw
- “There are old traders and there are bold traders, but there are very few old, bold traders.”-Ed Seykota
- “Let this scenario play out on its own, in its own fashion. As you watch it unfold, you will soon be grateful that you choose the peaceful path. Remember — those who live by the sword, die by the sword.”
- “As long as you enjoy investing, you’ll be willing to do the homework and stay in the game.” -Jim Cramer
- “I rarely think the market is right. I believe non-dividend stocks aren’t much more than baseball cards. They are worth what you can convince someone to pay for it.” -Mark Cuban
- “Michael Marcus taught me one other thing that is absolutely critical: You have to be willing to make mistakes regularly; there is nothing wrong with it. Michael taught me about making your best judgment, being wrong, making your next best judgment, being wrong, making your third best judgment, and then doubling your money.” -Bruce Kovner
- “The policy of being too cautious is the greatest risk of all.” -Jawaharlal Nehru
- “The only true test of whether a stock is “cheap” or “high” is not its current price in relation to some former price, no matter how accustomed we may have become to that former price, but whether the company’s fundamentals are significantly more or less favorable than the current financial-community appraisal of that stock.” -Philip Fisher
- “I learned to avoid trying to catch up or double up to recoup losses. I also learned that a certain amount of loss will affect your judgment, so you have to put some time between that loss and the next trade.” -Richard Dennis
- “The four most dangerous words in investing are: ‘this time it’s different.” -Sir John Templeton
- “Money doesn’t make you happy. I now have $50 million but I was just as happy when I had $48 million.” -Arnold Schwarzenegger
Videos
Please consider viewing these interesting videos:
Post View Count : 501